Sale of 2,900 shares at $92.3689 per share.
Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S
Traded Sep 21, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-09-21. https://desqlong.com/cards/0000907654-26-000100-2 (retrieved 2026-09-26).